ID 1681 -
Dekstryny z pszenicy
PL: Dekstryny z pszenicy
EN: Wheat dextrin
Pdf: wheat dextrin
Oświadczenie (2)
- jelit zdrowia / pokarmowego zdrowia / wypróżnienia
- pszenicy dekstryna
- naturalne lub zdrowej mikroflory równowagi
- jelit zdrowia / produkcja SCFA
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the claim is “wheat dextrin”.
Based on the information provided, the wheat dextrin that is the subject of the claim has a mean molecular weight of 5,344g/mol. The degree of polymerisation is from 15 to 18 glucose units of which 24 % in α-1,6 linkage (Pasman et al., 2006; Van Den Heuvel et al., 2004; Vermorel et al., 2004).
The Panel notes that the food constituent which is the subject of the health claims is a specific commercial preparation of wheat dextrin.
The Panel considers that the food constituent, wheat dextrin in the specific preparation, which is the subject of this opinion is sufficiently characterised in relation to the claimed effects.
2.6. Produkcja krótkołańcuchowych kwasów tłuszczowych (SCFA) w przewodzie pokarmowym (ID 1681)
The claimed effect is “bowel health/SCFA production”. The Panel assumes that the target population is the general population.
The Panel assumes that the claimed effect refers to the production of short chain fatty acids (SCFA) in the bowel.
The Panel considers that the evidence provided does not establish that SCFA production in the bowel is a beneficial physiological effect.
The Panel concludes that a cause and effect relationship has not been established between the consumption of “wheat dextrin” and a beneficial physiological effect related to SCFA production in the bowel.
2.7. Zmniejszenie ilości potencjalnie patogennych mikroorganizmów przewodu pokarmowego (ID 843, 1681)
The claimed effects are “bowel health/digestive health/bowel movement” and “bowel health/SCFA production”. The Panel assumes that the target population is the general population.
In the context of the proposed wording, the Panel assumes that the claimed effects refer to changes in the number of gastro-intestinal microorganisms.
The numbers/proportions of bacterial groups that would constitute a “natural or healthy balance microflora” have not been established. Increasing the number of any groups of microorganisms is not considered to be a beneficial physiological effect. The Panel considers that the evidence provided does not establish that the claimed effect in the context of increasing the numbers of gastro-intestinal microorganisms is a beneficial physiological effect.
The Panel considers that decreasing potentially pathogenic gastro-intestinal microorganisms might be a beneficial physiological effect.
3.6. Zmniejszenie ilości potencjalnie patogennych mikroorganizmów przewodu pokarmowego (ID 843, 1681)
Nine references were cited for the substantiation of the claim. None of these references evaluated the effect of wheat dextrin consumption on potentially pathogenic gastro-intestinal microorganisms. The Panel considers that no conclusions can be drawn from these references for the scientific substantiation of the claim.
The Panel concludes that a cause and effect relationship has not been established between the consumption of “wheat dextrin” and decreasing potentially pathogenic gastro-intestinal microorganisms.
Warunki i możliwe ograniczenia stosowania oświadczenia
AI for total fiber (IOM): 26-38 g/day
(ideally 8.5-12.5 g/day soluble fiber)